Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 798Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3SANOFI AVENTIS US

02 3ACCORD HLTHCARE

03 3ACTAVIS LABS FL INC

04 3AUROBINDO PHARMA LTD

05 3CARLSBAD

06 3CHARTWELL MOLECULAR

07 3DR REDDYS LABS LTD

08 3EPIC PHARMA LLC

09 3HIKMA PHARMS

10 3INDOCO REMEDIES

11 6MICRO LABS

12 3MYLAN

13 3NORVIUM BIOSCIENCE

14 4PRINSTON INC

15 2RANBAXY

16 4RANBAXY LABS LTD

17 2SANDOZ

18 5SB PHARMCO

19 2TAKEDA PHARMS USA

20 3TEVA

21 5TEVA PHARMS USA

22 3WATSON LABS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code : AB

GLIMEPIRIDE

Brand Name : AMARYL

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Approval Date : 1995-11-30

Application Number : 20496

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code : AB

GLIMEPIRIDE

Brand Name : AMARYL

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Approval Date : 1995-11-30

Application Number : 20496

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Sanofi Company Banner

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code : AB

GLIMEPIRIDE

Brand Name : AMARYL

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Approval Date : 1995-11-30

Application Number : 20496

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Sanofi Company Banner

04

SB PHARMCO

U.S.A
2024 ACI Convention
Not Confirmed
arrow

SB PHARMCO

U.S.A
arrow
2024 ACI Convention
Not Confirmed

GLIMEPIRIDE; ROSIGLITAZONE MALEATE

Brand Name : AVANDARYL

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2005-11-23

Application Number : 21700

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

05

SB PHARMCO

U.S.A
2024 ACI Convention
Not Confirmed
arrow

SB PHARMCO

U.S.A
arrow
2024 ACI Convention
Not Confirmed

GLIMEPIRIDE; ROSIGLITAZONE MALEATE

Brand Name : AVANDARYL

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2005-11-23

Application Number : 21700

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

06

SB PHARMCO

U.S.A
2024 ACI Convention
Not Confirmed
arrow

SB PHARMCO

U.S.A
arrow
2024 ACI Convention
Not Confirmed

GLIMEPIRIDE; ROSIGLITAZONE MALEATE

Brand Name : AVANDARYL

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2005-11-23

Application Number : 21700

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

07

SB PHARMCO

U.S.A
2024 ACI Convention
Not Confirmed
arrow

SB PHARMCO

U.S.A
arrow
2024 ACI Convention
Not Confirmed

GLIMEPIRIDE; ROSIGLITAZONE MALEATE

Brand Name : AVANDARYL

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2007-03-30

Application Number : 21700

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

08

SB PHARMCO

U.S.A
2024 ACI Convention
Not Confirmed
arrow

SB PHARMCO

U.S.A
arrow
2024 ACI Convention
Not Confirmed

GLIMEPIRIDE; ROSIGLITAZONE MALEATE

Brand Name : AVANDARYL

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2007-03-30

Application Number : 21700

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE

Brand Name : DUETACT

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG;30MG

Approval Date : 2006-07-28

Application Number : 21925

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE

Brand Name : DUETACT

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG;30MG

Approval Date : 2006-07-28

Application Number : 21925

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank